EntryPoint Capital’s CVRx CVRX Stock Holding History

EntryPoint Capital’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-501	Closed	-$9.12K	–	1035
2024 Q1	$9.12K	Buy	+501	New	+$11.9K	0.01%	1252

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

EntryPoint Capital's CVRX Position: Q2 2024 in Review

EntryPoint Capital sold out of CVRx (CVRX) in Q2 2024, closing a stake of 501 shares — an estimated $9.12K sold.

EntryPoint Capital first reported a position in CVRX in Q1 2024 and held it in 1 quarter. The position peaked at $9.12K in Q1 2024. 73 funds tracked by Wall St. Rank hold CVRX as of Q2 2024.

EntryPoint Capital reported no remaining CVRx position as of Q2 2024 after selling out during the quarter.
EntryPoint Capital sold 501 CVRx shares in Q2 2024, an estimated $9.12K.
EntryPoint Capital first reported a position in CVRx in Q1 2024 and held it in 1 quarter.
EntryPoint Capital's CVRx position peaked at $9.12K in Q1 2024.
73 funds tracked by Wall St. Rank held CVRx as of Q2 2024.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.